The Democratic Republic of the Congo has officially launched its targeted mpox vaccination campaign in the eastern city of Goma, administering the nation's first preventative doses against the escalating viral outbreak. The milestone immunization effort began at Goma's provincial general hospital, focusing immediately on medical doctors, nurses, and laboratory staff on the frontlines of patient care.
Public health officials mobilized an initial consignment of 265,000 doses of the MVA-BN vaccine, manufactured by Bavarian Nordic and donated through bilateral partnerships with the European Union and the United States Government. Health teams initiated dual-dose regimens designed to provide robust cellular immunity against the emerging Clade 1b variant.
Rollout of Donated MVA-BN Doses to Frontline Medical Personnel
North Kivu province and neighboring South Kivu have emerged as the primary epicenters of the continental epidemic, exacerbated by protracted regional conflict, civilian displacement, and crowded camp conditions. Healthcare workers have faced severe exposure risks while treating patients suffering from painful lesions, systemic fever, and secondary respiratory complications.
Epidemiologists from the World Health Organization and the Africa Centres for Disease Control and Prevention are collaborating on the ground with Congolese sanitary authorities to maintain cold-chain storage integrity. Specialized solar-powered refrigeration units have been deployed across urban clinics to preserve vaccine efficacy in tropical field environments.
“Administering our first vaccines in Goma marks a decisive operational turning point in protecting healthcare staff and containing mpox transmission across central Africa.” — Roger Kamba, Minister of Public Health, Hygiene and Prevention of the DRC
Epidemic Epicenter in Eastern Congo and Global Logistics Response
Beyond hospital personnel, the national strategic response plan designates high-risk contacts, sexual health workers, and forest-fringe communities as secondary priority cohorts. Health authorities are conducting community sensitization forums in Swahili and French to dispel misinformation and ensure broad voluntary uptake among vulnerable populations.
International health bodies have pledged to deliver millions of additional vaccine doses as manufacturing pipelines scale up globally. DRC health leadership stressed that sustained international financing, diagnostics access, and clinical therapeutics remain essential to halting cross-border spread throughout the Great Lakes region.
Frequently Asked Questions
Where did the DRC launch its mpox vaccination campaign?
The vaccination campaign was officially launched in Goma, the provincial capital of North Kivu in eastern DR Congo.
Which vaccine is being administered in the DRC rollout?
The campaign is administering the two-dose MVA-BN vaccine donated by the European Union and the United States.
Comments (0)
Log in to join the discussion.